Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

MIRAGE Study: Clinical Outcomes of the Mamba Sirolimus-Eluting PTCA Balloon

NCT07326735 is registered in ClinicalTrials.gov with Frisch Medical Device Private Limited as lead sponsor.

NCT NCT07326735
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07326735 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
MIRAGE Study: Clinical Outcomes of the Mamba Sirolimus-Eluting PTCA Balloon
Lead sponsor
Frisch Medical Device Private Limited
Phase
Phase 4
Overall status
Completed
Start date
January 11, 2023
Completion date
March 3, 2024
Enrollment
360 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

coronary artery disease (cad) (e.g., angina, myocardial infarction, and atherosclerotic heart disease (ashd))